DRX DLY HEALTHCARE BULL 3X (CURE) Stock Technical Analysis
NYSEARCA:CURE • US25459Y8764
Overall CURE gets a technical rating of 5 out of 10. In the last year, CURE was a medium performer in the overall market. The medium term is still looking fine, but we see some doubts in the very recent evolution.
- The short term is neutral, but the long term trend is still positive. Not much to worry about for now.
- CURE is currently trading in the upper part of its 52 week range. The S&P500 Index however is currently trading near a new high, so CURE is lagging the market slightly.
- In the last month CURE has a been trading in the 106.96 - 120.16 range, which is quite wide. It is currently trading in the middle of this range where prices have been consolidating recently, this may present a good entry opportunity, but some resistance may be present above.
- When compared to the yearly performance of all other stocks, CURE outperforms 48% of them, which is more or less in line with the market.
Although the technical rating is only medium, CURE does present a nice setup opportunity. Prices have been consolidating lately and the volatility has been reduced. There is very little resistance above the current price. There is a support zone below the current price at 114.29, a Stop Loss order could be placed below this zone.
More info and screens
107.11
We found 1 important support area.
- A support zone ranging from 108.19 to 114.29. This zone is formed by a combination of multiple trend lines and important moving averages in multiple time frames.
3 important resistance areas can be observed.
- Resistance @114.80 from a trend line in the weekly time frame.
- Resistance @118.07 from a horizontal line in the weekly time frame.
- A resistance zone ranging from 120.78 to 121.73. This zone is formed by a combination of multiple trend lines in the daily time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for CURE is up. |
| ChartMill Short Term Trend Indicator | NEUTRAL | NEUTRAL | The short term trend for CURE is neutral. |
| ChartMill Relative Strength | 48.42 | NEUTRAL | CURE is not amongst the best or worst performers on the market. |
| Simple Moving Average/SMA (20) | DOWN | MIXED | The current price of CURE is above a declining SMA(20). |
| Simple Moving Average/SMA (50) | UP | POSITIVE | The current price of CURE is above the rising SMA(50). |
| Simple Moving Average/SMA (200) | UP | POSITIVE | The current price of CURE is above the rising SMA(200). |
| Relative Strength Index/RSI (14) | 52.45 | NEUTRAL | The RSI value for CURE is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0.35 | POSITIVE | The MACD value suggests CURE has a positive trend, although the MACD value is declining. |
| Stochastics (14,3) | 71.22 | NEUTRAL | The Stochastics value for CURE is a neutral value. |
| Average True Range in percent/ATR (20) | 3.69 | MEDIUM VOLATILITY | The ATR as a percentage value for CURE suggests some volalility. |
| Average Directional Index/ADX (14) | 9.44 | NEGATIVE | The low ADX value for CURE suggests a weak or negative trend. |
NYSEARCA:CURE (2/19/2026, 8:04:00 PM)
114.5
-0.99 (-0.86%)
DRX DLY HEALTHCARE BULL 3X / CURE FAQ
What is the ChartMill technical rating of DRX DLY HEALTHCARE BULL 3X (CURE) stock?
ChartMill assigns a technical rating of 5 / 10 to CURE.
What is the trend direction for CURE stock?
The current trend direction for DRX DLY HEALTHCARE BULL 3X (CURE) is Bullish.
What is the RSI signal for DRX DLY HEALTHCARE BULL 3X (CURE) stock?
DRX DLY HEALTHCARE BULL 3X (CURE) has an RSI value of 52.4529. This indicates that the stock is currently neutral.
What is the short term momentum for CURE stock?
The short term momentum for DRX DLY HEALTHCARE BULL 3X (CURE) is neutral.